Back to VA VANGUARD CAPITAL MANAGEMENT LLC
HRTX2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in HERON THERAPEUTICS INC
Yes. Vanguard Capital Management holds 7,782,741 shares of HRTX (Heron Therapeutics), worth $3.3M, as of its Q2 2026 13F filing. It reduced the position by 27,588 shares (-0.4%) from Q1 2026. Vanguard Capital Management has held HRTX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$3.3M
Current Shares
7.8M
Total Value Change
-$2.9M
Total Shares Change
-27,588
Quarter-by-Quarter History
Other major holders of HRTX: FRANKLIN TEMPLETON INC